A community-based study of chronic kidney disease among type 2 diabetics in Kinmen, Taiwan

Diabetes Research and Clinical Practice

Volumn 75, Issue 3, 2007, Pages 306-312

  Lin, Ching Heng ^a   Yang, Wu Chang ^a,b   Tsai, Shih Tzer ^b   Tung, Tao Hsin ^c   Chou, Pesus ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c CHENG HSIN REHABILITATION MEDICAL CENTER   (Taiwan)

Author keywords

Proteinuria; Renal impairment; Type 2 diabetes mellitus

Indexed keywords

CREATININE; PROTEIN;

ADULT; AGED; ARTICLE; BODY SURFACE; CHRONIC KIDNEY DISEASE; COMMUNITY; CREATININE URINE LEVEL; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PROTEINURIA; SCREENING; TAIWAN;

ADULT; AGED; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; PROTEINURIA; QUESTIONNAIRES; TAIWAN; VOLUNTARY HEALTH AGENCIES;

EID: 33846050872     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2006.06.028     Document Type: Article

References (30)

1. Ritz E., and Orth S.R. Nephropathy in patients with type 2 diabetes mellitus. N. Engl. J. Med. 341 (1999) 1127-1133
2. Held P.J., Port F.K., Blagg C.R., and Agodoa L.Y. The United States Renal Data System's 1990 Annual Data Report: an introduction. Am. J. Kidney Dis. (Suppl 2) 16 (1990) 1-106
3. Nelson R.G., Newman J.M., Knowler W.C., Sievers M.L., Kunzelman C.L., Pettitt D.J., et al. Incidence of end-stage renal disease in type 2 diabetes mellitus in Pima Indians. Diabetologia 31 (1988) 730-736
4. Kshirsagar A.V., Joy M.S., Hogan S.L., Falk R.J., and Colindres R.E. Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease: a systematic overview of randomized placebo-controlled trials. Am. J. Kidney Dis. 35 (2000) 695-707
5. Jafar T.H., Schmid C.H., Landa M., Giatras I., Toto R., Remuzzi G., et al. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann. Intern. Med. 135 (2001) 73-87
6. Barnett A.H., Bain S.C., Bouter P., Karlberg B., Madsbad S., Jervell J., et al. Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy. N. Engl. J. Med. 351 (2004) 1952-1961
7. Pedrini M.T., Levey A.S., Lau J., Chalmers T.C., and Wang P.H. The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis. Ann. Intern. Med. 124 (1996) 627-632
8. Kawazu S., Tomono S., Shimizu M., Kato N., Ohno T., Ishii C., et al. The relationship between early diabetic nephropathy and control of plasma glucose in non-insulin-dependent diabetes mellitus. The effect of glycemic control on the development and progression of diabetic nephropathy in an 8-year follow-up study. J. Diabetes Complications 8 (1994) 13-17
9. Ohkubo Y., Kishikawa H., Araki E., Miyata T., Isami S., Motoyoshi S., et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res. Clin. Pract. 28 (1995) 103-117
10. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification: Kidney Disease Outcome Quality Initiative. Am. J. Kidney Dis. 39 (2002) S1-S266.
11. Kramer H.J., Nguyen Q.D., Curhan G., and Hsu C.Y. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA 289 (2003) 3273-3277
12. Chadban S.J., Briganti E.M., Kerr P.G., Dunstan D.W., Welborn T.A., Zimmet P.Z., et al. Prevalence of kidney damage in Australian adults: the AusDiab kidney study. J. Am. Soc. Nephrol. 14 (2003) S131-S138
13. Chou P., Liao M.J., Kuo H.S., Hsiao K.J., and Tsai S.T. A population survey on the prevalence of diabetes in Kin-Hu, Kinmen. Diabetes Care 17 (1994) 1055-1058
14. World Health Organization, Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO Consultation. Part 1. Diagnosis and classification of diabetes mellitus, World Health Organization, Geneva, 1999.
15. Ginsberg J.M., Chang B.S., Matarese R.A., and Garella S. Use of single voided urine samples to estimate quantitative proteinuria. N. Engl. J. Med. 309 (1983) 1543-1546
16. Ruggenenti P., Gaspari F., Perna A., and Remuzzi G. Cross sectional longitudinal study of spot morning urine protein:creatinine ratio, 24 h urine protein excretion rate, glomerular filtration rate, and end-stage renal failure in chronic renal disease in patients without diabetes. BMJ 316 (1998) 504-509
17. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation Modification of Diet in Renal Disease Study Group. Ann. Intern. Med. 130 (1999) 461-470
18. Couchoud C., Pozet N., Labeeuw M., and Pouteil-Noble C. Screening early renal failure: cut-off values for serum creatinine as an indicator of renal impairment. Kidney Int. 55 (2000) 1878-1884
19. Garg A.X., Kiberd B.A., Clark W.F., Haynes R.B., and Clase C.M. Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III. Kidney Int. 61 (2002) 2165-2175
20. Ohno T., Kato N., Shimizu M., Ishii C., Ito Y., Tomono S., et al. Effect of age on the development or progression of albuminuria in non-insulin-dependent diabetes mellitus (NIDDM) without hypertension. Diabetes Res. 22 (1993) 115-121
21. Mogensen C.E., and Christensen C.K. Predicting diabetic nephropathy in insulin-dependent patients. N. Engl. J. Med. 311 (1984) 89-93
22. Viberti G.C., Hill R.D., Jarrett R.J., Argyropoulos A., Mahmud U., and Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1 (1982) 1430-1432
23. Selby J.V., FitzSimmons S.C., Newman J.M., Katz P.P., Sepe S., and Showstack J. The natural history and epidemiology of diabetic nephropathy. Implications for prevention and control. JAMA 263 (1990) 1954-1960
24. Mann J.F., Gerstein H.C., Pogue J., Bosch J., and Yusuf S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann. Intern. Med. 134 (2001) 629-636
25. Wheeler D.C. Lipids-what is the evidence for their role in progressive renal disease?. Nephrol. Dial. Transplant. 10 (1995) 14-16
26. Ribstein J., du Cailar G., and Mimran A. Combined renal effects of overweight and hypertension. Hypertension 26 (1995) 610-615
27. Kang D.H., Nakagawa T., Feng L., Watanabe S., Han L., and Mazzali M. A role for uric acid in the progression of renal disease. J. Am. Soc. Nephrol. 13 (2002) 2888-2897
28. Morales J.V., Weber R., Wagner M.B., and Barros E.J. Is morning urinary protein/creatinine ratio a reliable estimator of 24-hour proteinuria in patients with glomerulonephritis and different levels of renal function?. J. Nephrol. 17 (2004) 666-672
29. Rembold C.M. Number needed to screen: development of a statistic for disease screening. BMJ 317 (1998) 307-312
30. Coresh J., Wei G.L., McQuillan G., Brancati F.L., Levey A.S., Jones C., et al. Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994). Arch. Intern. Med. 161 (2001) 1207-1216